Publish date:

Two Consumer Goods Stocks Analysts Love

Jarden and Summer Infant receive "buy" recommendations from the majority of analysts covering their stocks.

BOSTON (TheStreet) -- Consumer-goods makers are some of analysts' least favorite companies. Still, there are great investments in the sector. Here are two of researchers' top picks. Both are expected to outperform indices by wide margins.




makes niche consumer products, including plastic cutlery, matches, rope, twine, toothpicks and clothes pins. During the past three years, Jarden has increased revenue 10% annually, on average. It has a market value of $2.6 billion.


: Jarden swung to a first-quarter loss of $59 million, or 66 cents, from a profit of $8.9 million, or 12 cents, a year earlier. Revenue grew 4.4%. The operating margin widened from 5.6% to 5.9%. Jarden has $951 million of cash and $2.9 billion of debt.


: Jarden has advanced 48% during the past year, outperforming U.S. indices. It trades at a price-to-projected-earnings ratio of 8.7, an 80% discount to its peer average. Its PEG ratio of 0.5 indicates a 50% discount to projected long-term growth.


: Of analysts covering Jarden, eight, or 73%, recommend purchasing its shares and three advise holding them. None suggest selling.


(C) - Get Report

expects the stock to rise 70% to $48.


(RY) - Get Report



(BCS) - Get Report

predicts that it will hit $39.


TST Recommends

Summer Infant

(SUMR) - Get Report

designs and sells health and safety products for children, including baby monitors, gates and blankets. Since 2007, Summer Infant has more than tripled revenue and net income each year, on average.


: First-quarter net income quadrupled to $1.8 million, or 11 cents. Revenue grew 27%. The operating margin extended from 2.9% to 6.5%. Summer Infant has $1.6 million of cash and $41 million of debt, equal to a debt-to-equity ratio of 0.6.


: Summer Infant has quadrupled during the past year, outpacing U.S. benchmarks. It sells for a price-to-projected-earnings ratio of 12, a 31% discount to its peer average. Its PEG ratio of 0.4 demonstrates a 60% discount to projected fair value.


: Of firms rating Summer Infant, all five advocate buying its shares.

Needham & Co.

offers a price target of $11, leaving a potential return of 36%.

Roth Capital

forecasts that the stock will hit $10. Summer Infant has a market value of $125 million.

-- Reported by Jake Lynch in Boston.


>>Five Energy Stocks to Buy Amid Correction

>>Three Small-Cap Picks from Top Hedge Fund

>>Analysts' Five Favorite Stocks: Time to Buy?

Follow TheStreet on


and become a fan on